跳至主要内容
临床试验/NCT02428439
NCT02428439Unknown不适用

Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression

Asan Medical Center1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2015年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
Evaluation of Suicidal ideation and behavior

研究概览

简要总结

The objective of this study is to identification of genetic markers and predictors of antidepressant-induced suicidality in youth depression. Participants who take the standardized pharmacotherapy (bupropion or lamotrigine) for depression will be observed for 8 weeks. They will do several scales and genetic tests at visit 1 (week 0), visit 3 (week 4) and visit 4 (week 8)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
11 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 11 and 18 years
  • Met the Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version (K-SADS-PL) diagnostic criteria for depressive episode or dysthymia
  • Intelligence quotient higher than 70 on the Korean Educational Developmental Institute's Wechsler Intelligence Scale for Children

排除标准

  • presence of intellectual disability
  • presence of hereditary disorder
  • past and/or current history of acquired brain injury, like cerebral palsy
  • presence of seizure, other neurological disorder or sensory impairments
  • past and/or current history of pervasive developmental disorder
  • past and/or current history of schizophrenia, bipolar disorder or psychosis
  • presence of severe learning disorder

研究组 & 干预措施

Increased suicidality

Increase in suicidal ideation after taking the standardized pharmacotherapy (bupropion or lamotrigine) during 8 weeks.

干预措施: bupropion or lamotrigine (Drug)

Non-increased suicidality

Non-increase of suicidal ideation after taking the standardized pharmacotherapy (bupropion or lamotrigine) during 8 weeks.

干预措施: bupropion or lamotrigine (Drug)

结局指标

主要结局

Evaluation of Suicidal ideation and behavior

时间窗: 8 weeks

Using Columbia-Suicide Severity Rating Scale(C-SSRS)

次要结局

  • Evaluation of treatment effect of antidepressants(CDRS)(8 weeks)
  • Evaluation of treatment effect of antidepressants (YMRS)(8 weeks)
  • Evaluation of treatment effect of antidepressants(P-GBI)(8 weeks)
  • Evaluation of treatment effect of antidepressants(CGI-S)(8 weeks)
  • Genome wide association analysis(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyo-Won Kim

Assistant professor, department of psychiatry, Asan Medical Center

Asan Medical Center

研究点 (1)

Loading locations...

相似试验